Copyright © 2025 Authors retain the copyright of this article. This article is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

@article{185439,
        author = {Kasak Chaudhary and Dr.Lekha Singh and Chhavi Rana and Rakesh Kumar Pandey and Navin Parmar and Pushpraj Mishra and Ashish Kumar Ray and Rohit Kumar Yadav},
        title = {INFLAMMATORY MARKERS IN THYROID DISEASE},
        journal = {International Journal of Innovative Research in Technology},
        year = {2025},
        volume = {12},
        number = {5},
        pages = {1374-1381},
        issn = {2349-6002},
        url = {https://ijirt.org/article?manuscript=185439},
        abstract = {The chronic autoimmune thyroid condition known as Hashimoto's thyroiditis (HT) results in systemic inflammation throughout the body, which enlarges the thyroid gland and produces hypothyroidism. The general features of HT include decreased thyroid follicles, increased titers of thyroid autoantibodies, anti-thyroid peroxidase (Anti-TPO), and anti-thyroglobulin (Anti-TG); thyroid gland hypertrophy; abnormal thyroid functions; morphological changes in thyroid sonography; and Hurthle cells with granular-pink cytoplasm. The neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR) , interleukin and systemic immune inflammatory index (SII), system inflammation response index (SIRI), and aggregate index of systemic inflammation (AISI) are examples of new blood inflammatory indices (henceforth BIIXs) that have been tested in nearly every clinical research field and found to be accurate in measuring inflammation, the state of systemic illness, and the prognosis.},
        keywords = {Thyroid disease, Epidemiology, Inflammatory marker such as CRP, MLR, NLR, PLR, and Interleukin.},
        month = {October},
        }